{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:58:37Z","timestamp":1787921917420,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000024","name":"canadian institute of health research","doi-asserted-by":"crossref","award":["93528"],"award-info":[{"award-number":["93528"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s40261-025-01476-1","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T13:58:20Z","timestamp":1757080700000},"page":"793-801","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Off-Label Prescription of Benzodiazepines: A Retrospective Cohort Study of Prescribing Prevalence in Primary Care"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1939-4217","authenticated-orcid":false,"given":"Kevin","family":"Trimm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Teresa","family":"Moraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e4rbel","family":"Kn\u00e4uper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Rahme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Gibson McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Tamblyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"issue":"7","key":"1476_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s40261-016-0397-8","volume":"36","author":"Y Murphy","year":"2016","unstructured":"Murphy Y, Wilson E, Goldner EM, Fischer B. Benzodiazepine use, misuse, and harm at the population level in Canada: a comprehensive narrative review of data and developments since 1995. Clin Drug Investig. 2016;36(7):519\u201330. https:\/\/doi.org\/10.1007\/s40261-016-0397-8.","journal-title":"Clin Drug Investig"},{"issue":"9","key":"1476_CR2","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/archinte.166.9.1021","volume":"166","author":"DC Radley","year":"2006","unstructured":"Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med. 2006;166(9):1021\u20136. https:\/\/doi.org\/10.1001\/archinte.166.9.1021.","journal-title":"Arch Intern Med"},{"issue":"6","key":"1476_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000502518","volume":"25","author":"H L\u00f3pez-Pelayo","year":"2019","unstructured":"L\u00f3pez-Pelayo H, Coma A, Gual A, Zara C, Lligo\u00f1a A. Call for action: benzodiazepine prescription prevalence analysis shows off-label prescription in one in eleven citizens. Eur Addict Res. 2019;25(6):320\u20139. https:\/\/doi.org\/10.1159\/000502518.","journal-title":"Eur Addict Res"},{"key":"1476_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1197\/jamia.M1887","volume":"13","author":"R Tamblyn","year":"2006","unstructured":"Tamblyn R, Huang A, Kawasumi Y, et al. The development and evaluation of an integrated electronic prescribing and drug management system for primary care. J Am Med Inform Assoc. 2006;13:148\u201359. https:\/\/doi.org\/10.1197\/jamia.M1887.","journal-title":"J Am Med Inform Assoc"},{"key":"1476_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2165\/11534580-000000000-00000","volume":"33","author":"T Eguale","year":"2010","unstructured":"Eguale T, Winslade N, Hanley JA, Buckeridge DL, Tamblyn R. Enhancing pharmaco-surveillance with systematic collection of treatment indication in electronic prescribing: a validation study in Canada. Drug Saf. 2010;33:559\u201367.","journal-title":"Drug Saf"},{"issue":"3","key":"1476_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1748-720X.2009.00408.x","volume":"37","author":"R Dresser","year":"2009","unstructured":"Dresser R, Frader J. Off-label prescribing: a call for heightened professional and government oversight. J Law Med Ethics. 2009;37(3):476\u201386. https:\/\/doi.org\/10.1111\/j.1748-720X.2009.00408.x.","journal-title":"J Law Med Ethics"},{"issue":"10","key":"1476_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/archinternmed.2012.340","volume":"172","author":"T Eguale","year":"2012","unstructured":"Eguale T, Buckeridge DL, Winslade NE, Benedetti A, Hanley JA, Tamblyn R. Drug, patient, and physician characteristics associated with off-label prescribing in primary care. Arch Intern Med. 2012;172(10):781\u20138. https:\/\/doi.org\/10.1001\/archinternmed.2012.340.","journal-title":"Arch Intern Med"},{"issue":"356","key":"1476_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j603","volume":"21","author":"J Wong","year":"2017","unstructured":"Wong J, Motulsky A, Abrahamowicz M, Eguale T, Buckeridge DL, Tamblyn R. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system. BMJ. 2017;21(356):j603. https:\/\/doi.org\/10.1136\/bmj.j603.","journal-title":"BMJ"},{"issue":"Suppl. 2","key":"1476_CR9","first-page":"28","volume":"66","author":"CP O\u2019Brien","year":"2005","unstructured":"O\u2019Brien CP. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry. 2005;66(Suppl. 2):28\u201333 (PMID: 15762817).","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1476_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1532-5415.2005.53108.x","volume":"53","author":"R Tamblyn","year":"2005","unstructured":"Tamblyn R, Abrahamowicz M, du Berger R, McLeod P, Bartlett G. A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users. J Am Geriatr Soc. 2005;53(2):233\u201341.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"1476_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1183\/09031936.00008014","volume":"44","author":"NT Vozoris","year":"2014","unstructured":"Vozoris NT, Fischer HD, Wang X, Stephenson AL, Gershon AS, Gruneir A, et al. Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J. 2014;44(2):332\u201340.","journal-title":"Eur Respir J"},{"issue":"1","key":"1476_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2296-10-1","volume":"10","author":"G Bartlett","year":"2009","unstructured":"Bartlett G, Abrahamowicz M, Grad R, Sylvestre MP, Tamblyn R. Association between risk factors for injurious falls and new benzodiazepine prescribing in elderly persons. BMC Fam Pract. 2009;10(1):1\u20138.","journal-title":"BMC Fam Pract"},{"key":"1476_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102507","volume":"70","author":"J Brandt","year":"2024","unstructured":"Brandt J, Bressi J, L\u00ea ML, Neal D, Cadogan C, Witt-Doerring J, et al. Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review. EClinicalMedicine. 2024;70:102507. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102507.","journal-title":"EClinicalMedicine"},{"issue":"1\u20132","key":"1476_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JRS-170737","volume":"29","author":"M Dooms","year":"2017","unstructured":"Dooms M, Killick J. Off-label use of medicines: the need for good practice guidelines. Int J Risk Saf Med. 2017;29(1\u20132):17\u201323. https:\/\/doi.org\/10.3233\/JRS-170737.","journal-title":"Int J Risk Saf Med"},{"key":"1476_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1468-0009.2007.00496.x","volume":"85","author":"M-P Pomey","year":"2007","unstructured":"Pomey M-P, Forest P-G, Palley HA, Martin E. Public\/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec\u2019s universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States. Milbank Q. 2007;85:469\u201398.","journal-title":"Milbank Q"},{"key":"1476_CR16","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1592\/phco.28.12.1443","volume":"28","author":"SM Walton","year":"2008","unstructured":"Walton SM, Schumock GT, Lee K-V, Alexander GC, Meltzer D, Stafford RS. Prioritizing future research on off-label prescribing: results of a quantitative evaluation. Pharmacotherapy. 2008;28:1443\u201352. https:\/\/doi.org\/10.1592\/phco.28.12.1443.","journal-title":"Pharmacotherapy"},{"key":"1476_CR17","unstructured":"DRUGDEX\u00ae System [Internet database]. Greenwood Village (CO): Thomson Micromedex; updated periodically."},{"issue":"2\u20133","key":"1476_CR18","first-page":"167","volume":"65","author":"V Saano","year":"1987","unstructured":"Saano V. GABA-benzodiazepine receptor complex and drug actions. Med Biol. 1987;65(2\u20133):167\u201373.","journal-title":"Med Biol"},{"issue":"Pt3","key":"1476_CR19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1042\/BST0320553","volume":"32","author":"KA Wafford","year":"2004","unstructured":"Wafford KA, Macaulay AJ, Fradley R, O\u2019Meara GF, Reynolds DS, Rosahl TW. Differentiating the role of gamma-aminobutyric acid type A (GABAA) receptor subtypes. Biochem Soc Trans. 2004;32(Pt3):553\u20136. https:\/\/doi.org\/10.1042\/BST0320553.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"1476_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.coph.2005.10.003","volume":"6","author":"U Rudolph","year":"2006","unstructured":"Rudolph U, M\u00f6hler H. GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr Opin Pharmacol. 2006;6(1):18\u201323. https:\/\/doi.org\/10.1016\/j.coph.2005.10.003.","journal-title":"Curr Opin Pharmacol"},{"issue":"5a","key":"1476_CR21","first-page":"875","volume":"30","author":"DD Breimer","year":"1980","unstructured":"Breimer DD, Jochemsen R, von Albert HH. Pharmacokinetics of benzodiazepines: short-acting versus long-acting. Arzneimittelforschung. 1980;30(5a):875\u201381.","journal-title":"Arzneimittelforschung"},{"key":"1476_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1001\/jamainternmed.2015.6058","volume":"176","author":"T Eguale","year":"2016","unstructured":"Eguale T, Buckeridge DL, Verma A, et al. Association of off-label drug use and adverse drug events in an adult population. JAMA Intern Med. 2016;176:55\u201363. https:\/\/doi.org\/10.1001\/jamainternmed.2015.6058.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"1476_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12877-022-03165-6","volume":"22","author":"DT Amari","year":"2022","unstructured":"Amari DT, Juday T, Frech FH, Wang W, Wu Z, Atkins N Jr, et al. Falls, healthcare resources and costs in older adults with insomnia treated with zolpidem, trazodone, or benzodiazepines. BMC Geriatr. 2022;22(1):484.","journal-title":"BMC Geriatr"},{"issue":"7526","key":"1476_CR24","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1136\/bmj.38623.768588.47","volume":"331","author":"J Glass","year":"2005","unstructured":"Glass J, Lanct\u00f4t KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefts. BMJ (Clin Res Ed). 2005;331(7526):1169.","journal-title":"BMJ (Clin Res Ed)."},{"issue":"4","key":"1476_CR25","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","volume":"106","author":"MA Bachhuber","year":"2016","unstructured":"Bachhuber MA, Hennessy S, Cunningham CO, Starrels JL. Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996\u20132013. Am J Public Health. 2016;106(4):686\u20138. https:\/\/doi.org\/10.2105\/AJPH.2016.303061.","journal-title":"Am J Public Health"},{"issue":"11","key":"1476_CR26","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.clinthera.2016.09.010","volume":"38","author":"JL Schroeck","year":"2016","unstructured":"Schroeck JL, Ford J, Conway EL, et al. Review of safety and efficacy of sleep medicines in older adults. Clin Ther. 2016;38(11):2340\u201372.","journal-title":"Clin Ther"},{"key":"1476_CR27","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.4614","volume":"6","author":"A Mokhar","year":"2018","unstructured":"Mokhar A, Tillenburg N, Dirmaier J, Kuhn S, H\u00e4rter M, Verthein U. Potentially inappropriate use of benzodiazepines and z-drugs in the older population: analysis of associations between long-term use and patient-related factors. PeerJ. 2018;6:e4614.","journal-title":"PeerJ"},{"issue":"1","key":"1476_CR28","first-page":"56","volume":"101","author":"L Croke","year":"2020","unstructured":"Croke L. Beers criteria for inappropriate medication use in older patients: an update from the AGS. Am Fam Physician. 2020;101(1):56\u20137.","journal-title":"Am Fam Physician"},{"key":"1476_CR29","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1177\/0269881110379307","volume":"24","author":"SJ Wilson","year":"2010","unstructured":"Wilson SJ, Nutt DJ, Alford C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010;24:1577\u2013601. https:\/\/doi.org\/10.1177\/0269881110379307.","journal-title":"J Psychopharmacol"},{"issue":"2","key":"1476_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1124\/pr.117.014381","volume":"70","author":"T Atkin","year":"2018","unstructured":"Atkin T, Comai S, Gobbi G. Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery. Pharmacol Rev. 2018;70(2):197\u2013245.","journal-title":"Pharmacol Rev"},{"issue":"2","key":"1476_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5664\/jcsm.6470","volume":"13","author":"MJ Sateia","year":"2017","unstructured":"Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307\u201349.","journal-title":"J Clin Sleep Med"},{"issue":"Suppl. 1","key":"1476_CR32","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-244X-14-S1-S1","volume":"14","author":"MA Katzman","year":"2014","unstructured":"Katzman MA, Bleau P, Blier P, Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada\/Association Canadienne des troubles anxieux and McGill University, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14(Suppl. 1):S1. https:\/\/doi.org\/10.1186\/1471-244X-14-S1-S1.","journal-title":"BMC Psychiatry"},{"key":"1476_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/0269881114525674","volume":"28","author":"DS Baldwin","year":"2014","unstructured":"Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28:403\u201339. https:\/\/doi.org\/10.1177\/0269881114525674.","journal-title":"J Psychopharmacol"},{"key":"1476_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000447034","volume":"85","author":"AF Carvalho","year":"2016","unstructured":"Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA. The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom. 2016;85:270\u201388. https:\/\/doi.org\/10.1159\/000447034.","journal-title":"Psychother Psychosom"},{"issue":"5","key":"1476_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/YIC.0000000000000316","volume":"35","author":"B Lim","year":"2020","unstructured":"Lim B, Sproule BA, Zahra Z, Sunderji N, Kennedy SH, Rizvi SJ. Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology. Int Clin Psychopharmacol. 2020;35(5):243\u201353. https:\/\/doi.org\/10.1097\/YIC.0000000000000316.","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"1476_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/acps.13582","volume":"148","author":"M Tournier","year":"2023","unstructured":"Tournier M, B\u00e9nard-Laribi\u00e8re A, Jollant F, Hucteau E, Diop PY, Jarne-Munoz A, et al. Risk of suicide attempt and suicide associated with benzodiazepine: a nationwide case crossover study. Acta Psychiatr Scand. 2023;148(3):233\u201341. https:\/\/doi.org\/10.1111\/acps.13582.","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"1476_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-019-2312-3","volume":"19","author":"V Cato","year":"2019","unstructured":"Cato V, Holl\u00e4ndare F, Nordenskj\u00f6ld A, Sellin T. Association between benzodiazepines and suicide risk: a matched case-control study. BMC Psychiatry. 2019;19(1):317. https:\/\/doi.org\/10.1186\/s12888-019-2312-3.","journal-title":"BMC Psychiatry"},{"key":"1476_CR38","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.16r02037","author":"TJ Dodds","year":"2017","unstructured":"Dodds TJ. Prescribed benzodiazepines and suicide risk: a review of the literature. Prim Care Companion CNS Disord. 2017. https:\/\/doi.org\/10.4088\/PCC.16r02037.","journal-title":"Prim Care Companion CNS Disord."},{"key":"1476_CR39","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1001\/archinternmed.2009.314","volume":"169","author":"EA Largent","year":"2009","unstructured":"Largent EA, Miller FG, Pearson SD. Going off-label without venturing off-course: evidence and ethical off-label prescribing. Arch Intern Med. 2009;169:1745\u20137. https:\/\/doi.org\/10.1001\/archinternmed.2009.314.","journal-title":"Arch Intern Med"},{"issue":"3","key":"1476_CR40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1592\/phco.26.3.323","volume":"26","author":"HJ Demonaco","year":"2006","unstructured":"Demonaco HJ, Ali A, Hippel Ev. The major role of clinicians in the discovery of off-label drug therapies. Pharmacotherapy. 2006;26(3):323\u201332. https:\/\/doi.org\/10.1592\/phco.26.3.323.","journal-title":"Pharmacotherapy"},{"key":"1476_CR41","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/pds.1825","volume":"18","author":"DT Chen","year":"2009","unstructured":"Chen DT, Wynia MK, Moloney RM, Alexander GCUS. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey. Pharmacoepidemiol Drug Saf. 2009;18:1094\u2013100. https:\/\/doi.org\/10.1002\/pds.1825.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1476_CR42","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1056\/NEJMp0802107","volume":"358","author":"RS Stafford","year":"2008","unstructured":"Stafford RS. Regulating off-label drug use\u2013rethinking the role of the FDA. N Engl J Med. 2008;358:1427\u20139. https:\/\/doi.org\/10.1056\/NEJMp0802107.","journal-title":"N Engl J Med"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01476-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-025-01476-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01476-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:36:36Z","timestamp":1758972996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-025-01476-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1476"],"URL":"https:\/\/doi.org\/10.1007\/s40261-025-01476-1","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"value":"19 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kevin Trimm, Maria-Teresa Moraga, B\u00e4rbel Kn\u00e4uper, Elham Rahme, Emily Gibson McDonald, and Robyn Tamblyn have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"Ethics approval for this research was granted by the McGill REB Office (study # A01-B02-02A), the Capitale Nationale Integrated University Health and Social Services Centre (study # 2011-2012-14), and the West-Central Montreal Integrated University Health and Social Services Centre (study # 16-100). Research was conducted in accordance with the standards of ethics outlined in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Consent was obtained from all patients and physicians who participated in this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The data used in this study are patient electronic health records and therefore cannot be shared openly to protect study participant privacy. The code used to process and analyze the data is available upon request. Please address requests for data or code to Dr. Robyn Tamblyn (robyn.tamblyn@mcgill.ca).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"KT: primary manuscript author. M-TM: data analysis. BK: manuscript reviewer and author. ER: manuscript reviewer and author. EGM: manuscript reviewer and author. RT: primary manuscript reviewer and author. All authors reviewed and approved the final manuscript and have agreed to be accountable for their work.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}